BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24022407)

  • 1. New and emerging therapies for advanced or metastatic soft tissue sarcoma.
    Gettys SC; Anderson JE; Davis JE
    J Oncol Pharm Pract; 2014 Aug; 20(4):288-97. PubMed ID: 24022407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT
    Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma.
    Kopp HG; Patel S; Brücher B; Hartmann JT
    Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Therapy for Advanced Soft Tissue Sarcoma.
    Sheng JY; Movva S
    Surg Clin North Am; 2016 Oct; 96(5):1141-56. PubMed ID: 27542647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer medical therapies for metastatic soft tissue sarcoma.
    Tiwari A; Gupta VG; Bakhshi S
    Expert Rev Anticancer Ther; 2017 Mar; 17(3):257-270. PubMed ID: 28103739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
    Hartmann JT; Patel S
    Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
    Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
    Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First-Line Therapy for Metastatic Soft Tissue Sarcoma.
    Meyer M; Seetharam M
    Curr Treat Options Oncol; 2019 Jan; 20(1):6. PubMed ID: 30675651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New therapies in soft tissue sarcoma.
    Vincenzi B; Frezza AM; Santini D; Tonini G
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):237-48. PubMed ID: 20465449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
    Sethi TK; Keedy VL
    Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pazopanib: a promising new agent in the treatment of soft tissue sarcomas.
    Kasper B; Hohenberger P
    Future Oncol; 2011 Dec; 7(12):1373-83. PubMed ID: 22112314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances of systemic treatment for adult soft-tissue sarcoma.
    Liu W; Jiang Q; Zhou Y
    Chin Clin Oncol; 2018 Aug; 7(4):42. PubMed ID: 30173532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldoxorubicin therapy for the treatment of patients with advanced soft tissue sarcoma.
    Seetharam M; Kolla KR; Ganjoo KN
    Future Oncol; 2018 Oct; 14(23):2323-2333. PubMed ID: 29869517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pazopanib in the treatment of soft tissue sarcoma.
    Schöffski P
    Expert Rev Anticancer Ther; 2012 Jun; 12(6):711-23. PubMed ID: 22716487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Histology-Specific Chemotherapy in Soft-Tissue Sarcomas].
    Kobayashi E; Kawai A
    Gan To Kagaku Ryoho; 2017 Jun; 44(6):468-472. PubMed ID: 28698435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trabectedin in soft tissue sarcomas.
    Petek BJ; Loggers ET; Pollack SM; Jones RL
    Mar Drugs; 2015 Feb; 13(2):974-83. PubMed ID: 25686274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced soft tissue sarcoma: conventional agents and promising new drugs.
    Wagner A
    J Natl Compr Canc Netw; 2007 Apr; 5(4):401-10. PubMed ID: 17442231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcoma.
    Ranieri G; Mammì M; Donato Di Paola E; Russo E; Gallelli L; Citraro R; Gadaleta CD; Marech I; Ammendola M; De Sarro G
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):322-9. PubMed ID: 24041629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
    De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A
    Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.